Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

PURPOSE: The clinical safety and efficacy of intravenous busulfan and fludarabine (IV Bu/Flu) myeloablative conditioning as well as graft-versus-host disease (GVHD) prophylaxis with high-dose, post-transplantation cyclophosphamide (PTCy) have been demonstrated independently in several single-institu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kanakry, Christopher G., O'Donnell, Paul V., Furlong, Terry, de Lima, Marcos J., Wei, Wei, Medeot, Marta, Mielcarek, Marco, Champlin, Richard E., Jones, Richard J., Thall, Peter F., Andersson, Borje S., Luznik, Leo
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209101/
https://ncbi.nlm.nih.gov/pubmed/25267759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.54.0625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados